SCHEMBL7064666

SCHEMBL7064666

Cc1ccc(S(=O)(=O)ON(N=Cc2ccc(O)cc2O)C(=N)N)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.38
MAPT P10636 6/20 0.38
MEN1 O00255 6/20 0.38
GAA P10253 3/20 0.38
NCOA1 Q15788 1/20 0.38
NCOA3 Q9Y6Q9 1/20 0.38
ALDH1A1 P00352 2/20 0.36
POLB P06746 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
ALOX12 P18054 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 4/20 0.35
MAPK1 P28482 2/20 0.35
HTT P42858 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
ALPL P05186 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7066436 0.91 CA2 (0.46) KMT2AMAPTMEN1GAAALDH1A1
SCHEMBL7065198 0.84 ATM (0.45) KMT2AMAPTMEN1GAAALDH1A1
SCHEMBL7065861 0.83 MAPT (0.53) KMT2AMAPTMEN1GAAALDH1A1
SCHEMBL914349 0.83 DHODH (0.41) KMT2AMAPTMEN1GAAALDH1A1
SCHEMBL7065963 0.80 MAPT (0.38) KMT2AMAPTMEN1ALDH1A1ALOX12
SCHEMBL7065078 0.79 ERN1 (0.41) KMT2AMAPTMEN1GAAALDH1A1
SCHEMBL7062480 0.79 ALDH1A1 (0.47) KMT2AMAPTMEN1GAAALDH1A1
SCHEMBL7065942 0.79 MAPT (0.44) KMT2AMAPTMEN1GAAALDH1A1
SCHEMBL7064614 0.79 MAPT (0.44) KMT2AMAPTMEN1GAAALDH1A1
SCHEMBL7064657 0.79 MAPT (0.41) KMT2AMAPTMEN1GAANCOA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313461-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS Melacure Therapeutics AB (SE) 2003-05-28 EP claimed
WO-2002011715-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS MELACURE THERAPEUTICS AB (SE) 2002-02-14 WO claimed